Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multidose Safety and Tolerability Study of Liposomal Amikacin for Inhalation (Arikace™) In Cystic Fibrosis Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Insmed Incorporated
ClinicalTrials.gov Identifier:
NCT00558844
First received: November 13, 2007
Last updated: October 6, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 29, 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):